Malignant Esophageal Neoplasm — Trials

Malignant Esophageal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,926 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 518
Recruiting: 303
Ph III recruiting: 41
Growth YoY: +2.4%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 28.5%
Trials / 1,000 deaths: 32.3 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (169)

clinicaltrialsPublishedShowing 151–160 of 160 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06173986	Immunotherapy in Combination With Chemoradiotherapy in Unresectable Locally Advanced Esophageal Cancer	recruiting	Phase 1 / Phase 2	50	Shanghai Chest HospitalOTHER	1	Dec 18, 2023	clinicaltrials
NCT06122493	Optimization of Treatment Strategy for Unresectable cN3 Esophageal Squamous Cell Carcinoma	recruiting	Phase 2	48	Ruijin HospitalOTHER	1	Nov 8, 2023	clinicaltrials